4Perese D A,Ulman J,Viola J,et al.A 6-hydroxydopamine-induced selective parkinsonian rat model[J].Brain Res,1989,494(2):285-293.
5Thomas I,Wang J,Takubo H,et al.A 6-hydroxydopamine-induced selective parkinsonian rat model:further biochemical and behavioral characterization[J].Exp Neurol,1994,126(2):159-167.
6Kluter H,V ieregge P,Stolzer H,et al.Defective production of interleukin-2 in patients with idiopathic Parkinsen disease[J].J Neurol Sci,1995,133 (1-2):134-139.
7Bessler H,Djaldetti R,Salman H,et al.IL-1 beta,IL-2,IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson disease[J].Biomed Pharmacother,1999,53(3):141.
8Fiszer U,Mix E,Fredrikson S,et al.Gama delta+T cell are increased in patients with Parkinsen disease[J].J Neurol Sci,1994,121(1):39-45.
9Bokor M,Fao A,Schnabel R,et al.Relationship between the immune system and the diseases of the central nervous system[J].Ther Hung,1992,40(2):51.
10Perese DA, Ulman J, Viola J, et aI. 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res 1989; 494:285.
